Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
Pegasys
Roche in hepatitis C drug deal with Ascletis in China
Roche in hepatitis C drug deal with Ascletis in China
Reuters
Ascletis Pharmaceuticals
China
hepatitis C
Pegasys
Roche
India Revokes Patent On Roche Hepatitis C Drug
India Revokes Patent On Roche Hepatitis C Drug
Pharmalot
hepatitis C
India
patents
Pegasys
Roche
Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
TheStreet.com
Anadys
hepatitis C
M&A
Merck
Pegasys
Pharmasset
RG7128
Roche
setrobuvir
Victrelis
Merck Girds For Hep C Battle With Roche Deal
Merck Girds For Hep C Battle With Roche Deal
TheStreet.com
Boceprevir
hepatitis C
Merck
Pegasys
Roche
Vertex Pharmaceuticals
Victrelis
News
Vertex, Merck Drugs Help More with Faster Cure for Hepatitis C in Studies
Bloomberg
hepatitis C
Merck
Pegasys
Roche
Telaprevir
Vertex Pharmaceuticals
News
Dang! This Drug Is Shining Brighter
Motley Fool
Boceprevir
hepatitis C
Merck
Pegasys
PegIntron
Roche
Telaprevir
Vertex Pharmaceuticals
»
Login
or
register
to post comments
News
Human Genome Hep C Drug Passes With a C
TheStreet.com
Albuferon
hepatitis C
Human Genome Sciences
Novartis
Pegasys
Roche
»
Login
or
register
to post comments
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT